Literature DB >> 18480223

Difficulties in diagnosing group o human immunodeficiency virus type 1 acute primary infection.

Cécile Henquell1, Christine Jacomet, Odile Antoniotti, Abdelhak Chaib, Christel Regagnon, Sylvie Brunet, Hélène Peigue-Lafeuille, Francis Barin.   

Abstract

We report a rare case of acute human immunodeficiency virus (HIV) type 1 group O infection in a French Caucasian woman. Her sexual partner was secondarily diagnosed with HIV infection, and transmission was confirmed by phylogenetic analysis. The unequal performance of many of the serologic and molecular assays commercially available leads to delays in diagnosis and affects patient management.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18480223      PMCID： PMC2446893          DOI： 10.1128/JCM.02217-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays.

Authors:  Thoai Duong Ly; Syria Laperche; Catherine Brennan; Ana Vallari; Anne Ebel; Jeffrey Hunt; Lynn Martin; David Daghfal; Gerald Schochetman; Sushil Devare
Journal:  J Virol Methods       Date:  2004-12-15       Impact factor: 2.014

2.  First identification of HIV-1 groups M and O dual infections in Europe.

Authors:  Denys Brand; Agnès Beby-Defaux; Muriel Macé; Sylvie Brunet; Alain Moreau; Cendrine Godet; Xavier Jais; Françoise Cazein; Caroline Semaille; Francis Barin
Journal:  AIDS       Date:  2004-12-03       Impact factor: 4.177

3.  Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.

Authors:  Said Zouhair; Sylvie Roussin-Bretagne; Alain Moreau; Sylvie Brunet; Syria Laperche; Michèle Maniez; Francis Barin; Martine Harzic
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

4.  Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes.

Authors:  Marie Gueudin; Jean Christophe Plantier; Véronique Lemée; Marie Paule Schmitt; Loic Chartier; Thomas Bourlet; Annick Ruffault; Florence Damond; Muriel Vray; François Simon
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-15       Impact factor: 3.731

5.  Geographical distribution of HIV-1 group O viruses in Africa.

Authors:  M Peeters; A Gueye; S Mboup; F Bibollet-Ruche; E Ekaza; C Mulanga; R Ouedrago; R Gandji; P Mpele; G Dibanga; B Koumare; M Saidou; E Esu-Williams; J P Lombart; W Badombena; N Luo; M Vanden Haesevelde; E Delaporte
Journal:  AIDS       Date:  1997-03-15       Impact factor: 4.177

6.  Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy.

Authors:  Sigall Kassutto; Mary N Johnston; Eric S Rosenberg
Journal:  Clin Infect Dis       Date:  2005-02-18       Impact factor: 9.079

7.  Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France.

Authors:  Caroline Semaille; Francis Barin; Francoise Cazein; Josiane Pillonel; Florence Lot; Denys Brand; Jean-Christophe Plantier; Pascale Bernillon; Stéphane Le Vu; Roselyne Pinget; Jean-Claude Desenclos
Journal:  J Infect Dis       Date:  2007-06-19       Impact factor: 5.226

8.  Subtype B human immunodeficiency virus (HIV) type 1 mutant that escapes detection in a fourth-generation immunoassay for HIV infection.

Authors:  Catherine Gaudy; Alain Moreau; Sylvie Brunet; Jean-Michel Descamps; Pascale Deleplanque; Denys Brand; Francis Barin
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948
  8 in total
  11 in total

1.  Pilot studies for development of an HIV subtype panel for surveillance of global diversity.

Authors:  Mark Manak; Silvana Sina; Bharathi Anekella; Indira Hewlett; Eric Sanders-Buell; Viswanath Ragupathy; Jerome Kim; Marion Vermeulen; Susan L Stramer; Ester Sabino; Piotr Grabarczyk; Nelson Michael; Sheila Peel; Patricia Garrett; Sodsai Tovanabutra; Michael P Busch; Marco Schito
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-24       Impact factor: 2.205

2.  Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms.

Authors:  Mohan Kumar Haleyur Giri Setty; Jikun Liu; Prerna Mahtani; Panhe Zhang; Bingchen Du; Viswanath Ragupathy; Krishnakumar Devadas; Indira K Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-15       Impact factor: 2.205

Review 3.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.

Authors:  J-C Plantier; M Djemai; V Lemée; A Reggiani; M Leoz; L Burc; A Vessière; D Rousset; J-D Poveda; C Henquell; A Gautheret-Dejean; F Barin
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

5.  Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.

Authors:  Mark W Pandori; John Hackett; Brian Louie; Ana Vallari; Teri Dowling; Sally Liska; Jeffrey D Klausner
Journal:  J Clin Microbiol       Date:  2009-06-17       Impact factor: 5.948

6.  Prolonged second diagnostic window for human immunodeficiency virus type 1 in a fourth-generation immunoassay: are alternative testing strategies required?

Authors:  C R Robert George; Peter W Robertson; M Josephine Lusk; Ross Whybin; William Rawlinson
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

7.  Large-scale analysis of the prevalence and geographic distribution of HIV-1 non-B variants in the United States.

Authors:  Michael T Pyne; John Hackett; Vera Holzmayer; David R Hillyard
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

8.  Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay.

Authors:  Susan H Eshleman; Leila Khaki; Oliver Laeyendecker; Estelle Piwowar-Manning; LeTanya Johnson-Lewis; Marla Husnik; Beryl Koblin; Thomas Coates; Margaret Chesney; Ana Vallari; Sushil G Devare; John Hackett
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731

9.  Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay.

Authors:  A Mühlbacher; H Schennach; J van Helden; T Hebell; G Pantaleo; P Bürgisser; C Cellerai; P Permpikul; M I Rodriguez; A Eiras; F Alborino; P Cunningham; M Axelsson; S Andersson; O Wetlitzky; C Kaiser; P Möller; G de Sousa
Journal:  Med Microbiol Immunol       Date:  2012-06-17       Impact factor: 3.402

10.  Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China.

Authors:  Jingwan Han; Siyang Liu; Wei Guo; Zuoyi Bao; Xiaolin Wang; Lin Li; Yongjian Liu; Daomin Zhuang; Hanping Li; Lei Jia; Tao Gui; Hongshuai Sui; Tianyi Li; Jingyun Li
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.